Table 1 Characteristics of leukemia patients
patient | Age(yr) | sex | sample | diagnosis | blast(%) | Treatment | response | culture |
|---|---|---|---|---|---|---|---|---|
P1 | 50 | M | BM | M1 | 90 | MA | no | no |
P2 | 41 | M | BM | M2a | 62 | MA | CR | no |
P3 | 40 | F | BM | M2a | 81 | MA | CR | no |
P4 | 27 | F | BM | M3a | 92 | ATRA + AA | CR | no |
P5 | 27 | M | BM | M3a | 76 | ATRA + AA | CR | no |
P6 | 34 | M | BM | M3a | 68 | ATRA + AA | CR | no |
P7 | 16 | F | BM | M5a | 93 | MA | CR | no |
P8 | 78 | F | BM | M5b | 70 | MA | PR | no |
P9 | 12 | M | BM | M5b | 60 | MA | CR | no |
P10 | 6 | M | BM | L1 | 92 | VMLP | PR | no |
P11 | 48 | F | BM | L1 | 95 | VMLP | PR | no |
P12 | 48 | M | BM | L1 | 83 | VMLP | CR | no |
P13 | 17 | M | BM | L2 | 76 | VMLP | CR | no |
P14 | 46 | F | BM | L2 | 85 | VMLP | CR | no |
P15 | 66 | M | BM | L2 | 92 | VMLP | PR | no |
P16 | 66 | F | BM | L2 | 90 | VMLP | CR | no |
P17 | 36 | M | BM | L2 | 88 | VMLP | CR | no |
P18 | 42 | F | BM | BAL | 92 | MA + VP | PR | no |
P19 | 22 | M | BM | BAL | 80 | MA + VP | PR | no |
P20 | 50 | M | BM | M2a | 56 | MA | PR | yes |
P21 | 41 | M | BM | M2a | 92 | MA | PR | yes |
P22 | 10 | F | BM | M3a | 90 | ATRA + AA | CR | yes |
P23 | 12 | F | BM | M5b | 90 | MA | CR | yes |
P24 | 26 | M | BM | L1 | 76 | VMLP | PR | yes |
P25 | 16 | M | BM | L2 | 80 | VMLP | CR | yes |
P26 | 39 | M | BM | L2 | 82 | VMLP | CR | yes |
P27 | 78 | F | BM | BAL | 62.4 | MA + VP | PR | yes |